Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -$197,000.

  • Lifecore Biomedical's Net Cash Flow fell 47.15% to $2.8 million in Q2 2025 from the same period last year, while for May 2025 it was -$197,000, marking a year-over-year increase of 98.15%. This contributed to the annual value of -$197,000 for FY2025, which is 98.15% up from last year.
  • As of FY2025, Lifecore Biomedical's Net Cash Flow stood at -$197,000, which was up 98.15% from -$10.6 million recorded in FY2024.
  • Lifecore Biomedical's 5-year Net Cash Flow high stood at $17.4 million for FY2023, and its period low was -$10.6 million during FY2024.
  • Its 3-year average for Net Cash Flow is $2.2 million, with a median of -$197,000 in 2025.
  • As far as peak fluctuations go, Lifecore Biomedical's Net Cash Flow skyrocketed by 4,913.79% in 2023, and later plummeted by 160.92% in 2024.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Net Cash Flow stood at $742,000 in 2021, then tumbled by 53.10% to $348,000 in 2022, then spiked by 4,913.79% to $17.4 million in 2023, then slumped by 160.92% to -$10.6 million in 2024, then soared by 98.15% to -$197,000 in 2025.